Presidential Symposium

Sunday, October 24 | 8:00 a.m. - 12:30 p.m.

The 2021 Presidential Symposium “Advancing Person-centered Care Through Innovation” will showcase how innovation can improve patient outcomes and experience. New this year, in all sessions, patient speakers will share their perspectives.

In the first session, “Harnessing Scientific Innovation to Improve Person Centered Care”, advances in AI, imaging, real time planning, image guidance, radiopharmaceuticals, FLASH and biomarkers will be discussed. The second session, “Digital Health to Improve Patient Outcomes and Experience”, includes talks on crowdsourcing, equitable digital health, patient reported outcomes and successful implementation of digital advances to the clinic. The third session will highlight some potentially paradigm changing applications of radiation therapy, such as the rapidly expanding role of radiation therapy in the treatment of oligometastases, radiation therapy as an immune modulator, and radiation therapy as a curative alternative to surgery for liver cancer.

The Symposium will end with a lively debate on randomized clinical trials versus real world data, concluding with a vote and panel discussion featuring patient advocate and survivor, Jill Feldman. This is a Presidential Symposium you won’t want to miss!

Introduction and Session I: Harnessing Scientific Innovation

8:00 a.m. - 8:15 a.m.

Topic Speaker(s)
Introductions Laura Dawson, MD, Princess Margaret Hospital
Innovating with Compassion Shekinah Elmore, MD, University of North Carolina Chapel Hill

8:15 a.m. - 9:25 a.m.

Topic Speaker(s)
Introduction: Harnessing Innovation to Drive Patient-Centered Care Kristy Brock, PhD, Anderson Cancer Center
Artificial Intelligence Improving Person-Centered Care Hugo Aerts, PhD, Brigham and Women's Hospital
Innovations in Radiation Delivery: Real-Time Planning and Image Guidance Carri Glide-Hurst, PhD, University of Wisconsin
Transforming Radiotherapy with Ultra High Dose Rates (FLASH)  Magdalena Bazalova-Carter, PhD, University of Victoria
Advanced Imaging for Bioadaptive Radiotherapy Cynthia Menard, MD, Centre Hospitalier de l'Universite de Montreal (CHUM)
Patient Centered Radiopharmaceutical Therapy Ana Kiess, MD, PhD, Johns Hopkins University
Personalizing Radiation Therapy Using Molecular Biomarkers Felix Feng, MD, University of California, San Francisco
Patient Perspective (Video) Barney Morris
Session II: Digital Health to Improve Patient Outcomes and Experience

9:25 a.m. - 10:30 a.m.

Moderators:
Adam Dicker, MD, PhD, Thomas Jefferson University
Karen Winkfield, MD, PhD, Vanderbilt University Medical Center

Topic Speaker(s)
Key Actors – Patients and Crowdsourcing Jen Horonjeff
(e) PROMs/PREMs as the True North – Why/When/How Deb Schrag, MD, Dana-Farber Cancer Institute
Reducing Disparities with Digital Innovation Edmondo Robinson, MD, H. Lee Moffitt Cancer Center and Research Institute
Implementing: From "Code" to "Clinic Ale Berlin, MD, Princess Margaret Cancer Center
Panel Discussion All Speakers
Reflections/Lessons Learned in Radiation Oncology Digital Health Nitin Ohri, MD, Albert Einstein College of Medicine
Session III: Aiming to Improve Patient Outcomes

10:30 a.m. - 11:30 a.m.

Moderators
Sue Evans, MD, Yale University
Iris Gibbs, MD, Stanford University

Topic Speaker(s)
Patient Perspective (Video) Mitchell Tarkoff
Beyond Oligometastases: New Frontiers for Stereotactic Radiation David Palma, MD, PhD, London Health Sciences Center
Innovative Immune Targeting/TME/RT as Vaccine Chandan Guha, MD, PhD, Montefiore Medical Center
Radiation as a Curative Therapy in Hepatocellular Carcinoma Jinsil Seong, MD, PhD, Severance Hospital of the Yonsei University Health System
Rethinking Radiation Timing and Surgical Perturbation Failure Stuart Burri, MD, Levine Cancer Institute
Targeting Nerve Pain Yaacov Lawrence, MD, Sheba Medical Center
Session IV: Obtaining Evidence for Change

11:30 a.m. - 12:25 p.m.

Moderators:
Sue Yom, MD, PhD, University of California, San Francisco
Gita Suneja, MD, University of Utah Huntsman Cancer Institute

Topic Speaker(s)
Moderators Sue Yom, MD, PhD, University of California, San Francisco and Gita Suneja, MD, University of Utah Huntsman Cancer Institute
Pro: Randomized Controlled Trials (RCT) Soren Bentzen, DSc, PhD, University of Maryland School of Medicine
Pro: Real World Data (RWD) Corinne Faivre-Finn, MD, PhD, The University of Manchester
Rebuttal: Randomized Clinical Trials (RCT) Reshma Jagsi, MD, PhD, University of Michigan
Rebuttal: Real World Data (RWD) Dave Fuller, MD, PhD, MD Anderson Cancer Center
Vote and Panel with Additional Speaker  
Patient Perspective Jill Feldman, Special Guest, Patient Perspective, EGFR Resisters

American Society for Radiation Oncology
251 18th Street South, 8th Floor
Arlington, VA 22202
Telephone: 703-502-1550
www.astro.org

TERMS OF USE & PRIVACY POLICY

Connect With Us: